Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluated the efficacy and safety of risperidone for the prevention of mood episodes in patients with Bipolar I Disorder; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-11-01